Patent · US Active

Method of treating hereditary angioedema using plasma kallikrein binding antibodies

US9266964B2 · kind B2 · utility

20Cited by
157References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 20, 2014
Grant dateFeb 23, 2016
Priority date—
Expiry dateJun 20, 2034

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2500/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Plasma kallikrein binding proteins and methods of using such proteins are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.